429 related articles for article (PubMed ID: 15893928)
1. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new pyrazole derivatives and their anticancer evaluation.
Nitulescu GM; Draghici C; Missir AV
Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
5. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.
Daidone G; Raffa D; Maggio B; Valeria Raimondi M; Plescia F; Schillaci D
Eur J Med Chem; 2004 Mar; 39(3):219-24. PubMed ID: 15051169
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
Xia Y; Yang ZY; Xia P; Bastow KF; Nakanishi Y; Lee KH
Bioorg Med Chem Lett; 2000 Apr; 10(8):699-701. PubMed ID: 10782667
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
[TBL] [Abstract][Full Text] [Related]
9. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumorigenic chalcones.
Shibata S
Stem Cells; 1994 Jan; 12(1):44-52. PubMed ID: 8142919
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
17. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
18. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
Rostom SA
Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
[TBL] [Abstract][Full Text] [Related]
20. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
